ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $435,000 | -2.2% | 3,186 | -8.7% | 0.00% | 0.0% |
Q4 2020 | $445,000 | +4.5% | 3,488 | -6.7% | 0.00% | 0.0% |
Q3 2020 | $426,000 | -4.7% | 3,737 | -26.0% | 0.00% | 0.0% |
Q1 2020 | $447,000 | +10.1% | 5,049 | -33.6% | 0.00% | 0.0% |
Q4 2019 | $406,000 | +95.2% | 7,609 | +44.8% | 0.00% | – |
Q3 2019 | $208,000 | -11.1% | 5,254 | -7.7% | 0.00% | – |
Q2 2019 | $234,000 | +6.8% | 5,691 | +21.4% | 0.00% | – |
Q1 2019 | $219,000 | – | 4,689 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |